Animas IPO: Insulin Pump Maker Offers Up To $69 Mil. In Stock
This article was originally published in The Gray Sheet
Executive Summary
Proceeds from Animas Corp.'s initial public offering will support sales and marketing of the IR 1200 third-generation insulin pump and evaluation of continuous glucose sensor technology licensed from Thomas Jefferson University, the manufacturer notes
You may also be interested in...
Animas Stock Pumped Up 22% By Takeover Speculation In February – Index
Continued strong demand for Animas insulin pumps is fueling forecasts by some investors of a potential merger with Johnson & Johnson
Animas Stock Pumped Up 22% By Takeover Speculation In February – Index
Continued strong demand for Animas insulin pumps is fueling forecasts by some investors of a potential merger with Johnson & Johnson
Animas Targets Profitability In 2005 Despite Insulin Pump Production Issues
Animas expects to clear up supplier issues hindering production of its IR1200 insulin pump by October, as increased demand tips the firm toward profitability in 2005, President & CEO Katherine Crothall says